ProteinQure Inc.
25.3.2024 05:03:30 CET | ACCESS Newswire | Press release
TORONTO, ON / ACCESSWIRE / March 25, 2024 / ProteinQure, the leading startup in the computational design of peptide drugs, announces a significant breakthrough in the fight against triple-negative breast cancer (TNBC). The novel Peptide Drug Conjugate (PDC) designed by ProteinQure demonstrated exceptional efficacy in a comprehensive suite of Patient-Derived Xenograft (PDX) models. The experiments were conducted in the lab of Dr. David Cescon at the Princess Margaret Cancer Centre/University Health Network, one of the world's top five cancer research centres.
Developed through ProteinQure's cutting-edge computational platform, the innovative SORT1 targeting PDC is a novel peptide attached to a highly potent chemotherapeutic agent. The drug candidate was tested across a broad range of breast cancer models. The results demonstrated remarkable antitumor efficacy, including cancers resistant to standard chemotherapies and antibody-drug conjugates.
"Working with the David Cescon Lab at UHN has been instrumental in validating our novel PDC's efficacy against one of the most challenging forms of breast cancer. Based on these results, we are moving our lead program forward into IND-Enabling studies and our first clinical trial," said Lucas Siow, CEO of ProteinQure. "These findings not only highlight the power of our computational drug design platform but also represent significant validation in our quest to develop tissue-specific peptides for targeted drug delivery."
ProteinQure's collaborators will present the data at the upcoming American Association for Cancer Research (AACR) conference in San Diego. The AACR conference, renowned for showcasing the latest innovations in cancer research, provides the perfect stage to share these findings with the global cancer research community.
"We are excited to present this data at AACR and help develop new therapeutic options for breast cancer, especially with promising Canadian startups," stated Dr. David Cescon, head of the lab at UHN. "The success of this unique PDC in diverse PDX models is a testament to the potential of combining advanced computational techniques, precision oncology, and our labs' robust preclinical platform".
Funding for parts of this work included contributions from IRAP-Canada and the INOVAIT program based out of Sunnybrook Hospital.
Poster Presentation Details:
Title: In-vivo efficacy of a novel peptide-conjugated drug in patient-derived xenograft models of breast cancer
Session Title: New Targets
Date and Time: Tuesday, April 9, at 1:30 p.m. PT/4:30 p.m. ET
Abstract Number: 5911
Speaker: Mitchell Elliott, UHN Princess Margaret Cancer Centre
About ProteinQure
ProteinQure is a pioneering startup specializing in the computational design of peptide drugs utilizing state-of-the-art artificial intelligence and molecular simulation technologies. With a focus on precision medicine, ProteinQure is dedicated to transforming the landscape of drug development and ushering in a new era of targeted effective treatments.
About the David Cescon Lab at UHN
The David Cescon Lab at the University Health Network is a leader in breast cancer research, focusing on the mechanisms of cancer progression and resistance to therapy. Through cutting-edge pre-clinical and clinical research and collaborations, the lab develops novel therapeutic strategies aimed at improving outcomes for cancer patients worldwide.
For further information, please contact:
Lucas Siow - CEO of ProteinQure - press@proteinqure.com
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
SOURCE: ProteinQure Inc.
View the original press release on accesswire.com
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Clockwork.io Introduces A New Class of Fault Tolerance to End Failure-Driven GPU Waste in AI Training11.3.2026 14:00:00 CET | Press release
New TorchPass solution addresses a multi-million dollar challenge with AI infrastructure; uses Live GPU Migration to keep large-scale AI training running through hardware failures instead of forcing costly restarts PALO ALTO, CA / ACCESS Newswire / March 11, 2026 / Clockwork.io, the leader in Software-Driven AI Fabrics™- a programmable, vendor-neutral software layer that optimizes large-scale GPU clusters for real-time observability, fault tolerance, and deterministic performance-today announced the general availability of TorchPass Workload Fault Tolerance. This new class of software-driven fault-tolerance eliminates one of the most costly failure modes in large-scale AI training: catastrophic job restarts caused by infrastructure faults. Delivered as a core capability of the Clockwork.io FleetIQ™ platform, TorchPass applies the principles of Software-Driven AI Fabrics to distributed training, using Live GPU Migration to allow workloads to continue running through GPU failures, networ
Datavault AI CEO Nathaniel Bradley to Present at Luminary 2026 During Oscars Weekend in Los Angeles11.3.2026 12:00:00 CET | Press release
Datavault AI (Nasdaq:DVLT) Debuts Tokenized Legacy™ Platform and ADIO® Technology at Beverly Center Alongside Scott Page's My Moon Experience, Pink Floyd Live Performance, and Entertainment Industry Luminaries PHILADELPHIA, PA / ACCESS Newswire / March 11, 2026 / Datavault AI Inc. ("Datavault AI" or the "Company") (NASDAQ:DVLT), a provider of data monetization, credentialing, digital engagement, and real‑world asset tokenization technologies, today announced that Chief Executive Officer Nathaniel (Nate) Bradley will deliver a featured presentation at Luminary 2026 - Film, AI, Music and Crypto Innovators, a premier conference taking place Saturday, March 14, 2026, at the Beverly Center (8500 Beverly Blvd, Suite 835, Los Angeles, CA 90048) as part of Oscars Weekend 2026. The Luminary 2026 event is produced by Space Blue/MMF (Dallas Santana) and Hollywood Road Show TV (Chantelle Borelli) and forms the centerpiece of a four-day entertainment and technology activation series running March 1
Context Management Powers Production-Ready AI Analytics at Enterprise Scale11.3.2026 09:00:00 CET | Press release
GoodData delivers governed semantics, grounded knowledge, guided behavior, and full observability for reliable AI analytics. SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / March 11, 2026 / GoodData today introduced Context Management, a governed contextual layer designed to enable production-ready enterprise AI analytics and agents. As organizations deploy AI assistants, copilots, and autonomous agents, they encounter a structural gap: AI lacks enforced business context, governance, and observability. AI pilots demonstrate potential, but moving AI into production exposes the deeper challenge of ensuring answers are consistent, safe, and explainable at scale. Without semantics and traceability, answers shift depending on phrasing. Business rules are applied inconsistently. When outputs change, teams can't explain why. For enterprises, this erodes trust and slows adoption. Many AI analytics platforms rely on prompts, inferred metadata, or loosely integrated document search. Context is sug
Telestream Expands Its Cloud Services with the Introduction of UP11.3.2026 08:05:00 CET | Press release
New cloud-native platform extends Telestream Cloud Services to support Global Ingest, automation, review, and real-time monitoring across hybrid and distributed production environments NEVADA CITY, CA / ACCESS Newswire / March 11, 2026 / Telestream, a global leader in media workflow technologies, today announced the expansion of Telestream Cloud Services with the introduction of UP, a new cloud-native solution designed to support Global Ingest, orchestration, review, and real-time monitoring in modern production environments. With UP, Telestream extends its cloud portfolio beyond high-scale cloud processing and hybrid workflow extension, addressing the growing operational demands of distributed, IP-based media production. As media organizations navigate cost pressures, audience fragmentation, and increasingly distributed production models, cloud adoption has accelerated rapidly but unevenly. Some companies are extending trusted workflows into elastic cloud environments. Others are buil
U.S. Polo Assn. Expands Collegiate Partnership Program to Record 70 Teams for 2026 Season5.3.2026 13:00:00 CET | Press release
WEST PALM BEACH, FLA. / ACCESS Newswire / March 5, 2026 / U.S. Polo Assn., the official sports brand of the United States Polo Association (USPA), proudly announces the continued expansion of its Collegiate Partnership Program (CPP) for the 2026 season and academic year. Now in its eighth consecutive year, the program reaches a historic milestone by supporting 70 collegiate teams across 31 universities nationwide, the largest number of teams ever participating in the program.U.S. Polo Assn.'s Collegiate Partnership Program featuring the California Polytechnic State University Women's and Men's Polo Teams Photo Credit: California Polytechnic State University Polo Teams U.S. Polo Assn. will outfit hundreds of student-athletes from coast to coast, including small private and large public institutions, Ivy League Universities, and Historically Black Colleges and Universities (HBCUs). The CPP supports 35 women's and 35 men's teams, reinforcing U.S. Polo Assn.'s long-standing commitment to g
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom